Cellular reprogramming to enable the precise and scalable manufacturing of human cells for therapeutic applications
Presenting key examples from external partners and collaborators, Davenport demonstrates how bit.bio’s core technology, opti-ox™, has been applied to created megakaryocytes, myogenic precursors and astrocytes.
Watch now to discover how bit.bio’s core technology:
- provides a solution to the bottlenecks of current cell therapies
- unlocks the potential of iPSCs for therapeutic applications
- has been applied to generate functional cells which have been validated in vivo
Dr Alex Davenport
bit.bio talk at ELRIG Cell & Gene Therapy